Major or Mild Vascular Neurocognitive Disorder

  • Amer M. Burhan
  • Manoosh Moradizadeh
  • Nicole E. Marlatt


Major or mild vascular neurocognitive disorders represent the second most common cause of neurocognitive disorders. The underlying cerebrovascular disease could be multiple strokes, limited but strategic strokes, and/or significant white matter hyperintensities. The main criterion to make this diagnosis is a probable or possible causal link between cerebrovascular disease and the neurocognitive disorder. The course, neuropsychological profile, prognosis, and treatment of these disorders differ from neurodegenerative illnesses like Alzheimer disease, but can be comorbid with them. In this chapter we will provide an evidence-based review of the background of this illness and give two illustrative case examples to consolidate learning.


Neurocognitive Vascular Stroke White matter hyperintensity Lacunae Infarcts 


  1. 1.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  2. 2.
    World Health Organization. ICD-10 Version: 2015.
  3. 3.
    Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974;2(7874):207–10.PubMedCrossRefGoogle Scholar
  4. 4.
    Moroney JT, Bagiella E, Hachinski VC, Molsa PK, Gustafson L, Brun A, et al. Misclassification of dementia subtype using the Hachinski Ischemic Score: results of a meta-analysis of patients with pathologically verified dementias. Ann N Y Acad Sci. 1997;826:490–2.PubMedCrossRefGoogle Scholar
  5. 5.
    Hachinski V, Oveisgharan S, Romney AK, Shankle WR. Optimizing the Hachinski Ischemic Scale. Arch Neurol. 2012;69(2):169–75.PubMedCrossRefGoogle Scholar
  6. 6.
    Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–60.PubMedCrossRefGoogle Scholar
  7. 7.
    Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42(3 Pt 1):473–80.PubMedCrossRefGoogle Scholar
  8. 8.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Associating Publishing; 1994.Google Scholar
  9. 9.
    Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol. 2000;57(2):191–6.PubMedCrossRefGoogle Scholar
  10. 10.
    O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89–98.PubMedCrossRefGoogle Scholar
  11. 11.
    Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–713.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Jellinger KA. The pathology of “vascular dementia”: a critical update. J Alzheimers Dis. 2008;14(1):107–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995;14(5):240–57.PubMedCrossRefGoogle Scholar
  14. 14.
    Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008;7(9):812–26.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Jin YP, Di Legge S, Ostbye T, Feightner JW, Hachinski V. The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement. 2006;2(3):171–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, Pondal M, Vivancos J, Del Ser T. Poststroke dementia : clinical features and risk factors. Stroke. 2000;31(7):1494–501.PubMedCrossRefGoogle Scholar
  17. 17.
    Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28(4):785–92.PubMedCrossRefGoogle Scholar
  18. 18.
    Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992;42(6):1185–93.PubMedCrossRefGoogle Scholar
  19. 19.
    Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc. 1999;47(5):564–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Neuropathology Group. Medical Research Council Cognitive F, Aging S. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet. 2001;357(9251):169–75.CrossRefGoogle Scholar
  21. 21.
    White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci. 2002;977:9–23.PubMedCrossRefGoogle Scholar
  22. 22.
    Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16(4):203–12.PubMedCrossRefGoogle Scholar
  23. 23.
    Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, Salviati A, et al. Vascular dementia in a population-based autopsy study. Arch Neurol. 2003;60(4):569–75.PubMedCrossRefGoogle Scholar
  24. 24.
    Fernando MS, Ince PG, Function MRCC. Ageing Neuropathology Study G. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci. 2004;226(1–2):13–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220–41.PubMedCrossRefGoogle Scholar
  26. 26.
    Black S, Gao F, Bilbao J. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke. 2009;40(3 Suppl):S48–52.PubMedCrossRefGoogle Scholar
  27. 27.
    Kalaria RN. Risk factors and neurodegenerative mechanisms in stroke related dementia. Panminerva Med. 2012;54(3):139–48.PubMedGoogle Scholar
  28. 28.
    Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, et al. APOE, vascular pathology, and the AD brain. Neurology. 2005;65(2):259–65.PubMedCrossRefGoogle Scholar
  29. 29.
    Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry. 1997;63(6):749–53.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann N Y Acad Sci. 2000;903:239–43.PubMedCrossRefGoogle Scholar
  31. 31.
    Pantoni L, Garcia JH. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann N Y Acad Sci. 1997;826:92–102.PubMedCrossRefGoogle Scholar
  32. 32.
    Markus H. Risk of stroke in asymptomatic carotid stenosis. Lancet. 1995;345(8951):721.PubMedCrossRefGoogle Scholar
  33. 33.
    Sahlas DJ, Bilbao JM, Swartz RH, Black SE. Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia. Ann Neurol. 2002;52(3):378–81.PubMedCrossRefGoogle Scholar
  34. 34.
    Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol. 2007;33(4):410–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol. 1986;45(1):79–90.PubMedCrossRefGoogle Scholar
  36. 36.
    Natte R, Vinters HV, Maat-Schieman ML, Bornebroek M, Haan J, Roos RA, et al. Microvasculopathy is associated with the number of cerebrovascular lesions in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Stroke. 1998;29(8):1588–94.PubMedCrossRefGoogle Scholar
  37. 37.
    Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991;30(5):637–49.PubMedCrossRefGoogle Scholar
  38. 38.
    Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna). 2002;109(5–6):813–36.CrossRefGoogle Scholar
  39. 39.
    Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011;69(2):320–7.PubMedCrossRefGoogle Scholar
  40. 40.
    O’Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45(4):652–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–605.PubMedCrossRefGoogle Scholar
  42. 42.
    Laurent S, Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension. 2007;49(6):1202–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension. 2005;45(6):1050–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Elias MF, Robbins MA, Budge MM, Abhayaratna WP, Dore GA, Elias PK. Arterial pulse wave velocity and cognition with advancing age. Hypertension. 2009;53(4):668–73.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Scuteri A, Brancati AM, Gianni W, Assisi A, Volpe M. Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: a pilot study. J Hypertens. 2005;23(6):1211–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Scuteri A, Tesauro M, Appolloni S, Preziosi F, Brancati AM, Volpe M. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens. 2007;25(5):1035–40.PubMedCrossRefGoogle Scholar
  47. 47.
    Hanon O, Haulon S, Lenoir H, Seux ML, Rigaud AS, Safar M, et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke. 2005;36(10):2193–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Waldstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension. 2008;51(1):99–104.PubMedCrossRefGoogle Scholar
  49. 49.
    Morovic S, Jurasic MJ, Martinic Popovic I, Seric V, Lisak M, Demarin V. Vascular characteristics of patients with dementia. J Neurol Sci. 2009;283(1–2):41–3.PubMedCrossRefGoogle Scholar
  50. 50.
    van Beek AH, Claassen JA, Rikkert MG, Jansen RW. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28(6):1071–85.PubMedCrossRefGoogle Scholar
  51. 51.
    Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178–201.PubMedCrossRefGoogle Scholar
  52. 52.
    Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci. 2004;5(5):347–60.PubMedCrossRefGoogle Scholar
  53. 53.
    Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008;7(6):476–84.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Iadecola C, Park L, Capone C. Threats to the mind: aging, amyloid, and hypertension. Stroke. 2009;40(3 Suppl):S40–4.PubMedCrossRefGoogle Scholar
  55. 55.
    Zacchigna S, Lambrechts D, Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci. 2008;9(3):169–81.PubMedCrossRefGoogle Scholar
  56. 56.
    Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, et al. Links between the pathology of Alzheimer’s disease and vascular dementia. Neurochem Res. 2004;29(6):1257–66.PubMedCrossRefGoogle Scholar
  57. 57.
    Dichgans M. Genetics of ischaemic stroke. Lancet Neurol. 2007;6(2):149–61.PubMedCrossRefGoogle Scholar
  58. 58.
    Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580(13):2994–3005.PubMedCrossRefGoogle Scholar
  59. 59.
    Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr. 2004;80(1):114–22.PubMedGoogle Scholar
  60. 60.
    Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci. 1977;34(2):247–65.PubMedCrossRefGoogle Scholar
  61. 61.
    Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging. 2006;27(12):1769–85.PubMedCrossRefGoogle Scholar
  62. 62.
    White L, Small BJ, Petrovitch H, Ross GW, Masaki K, Abbott RD, et al. Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol. 2005;18(4):224–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009;18(3):691–701.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol. 2007;62(4):406–13.PubMedCrossRefGoogle Scholar
  65. 65.
    Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197–204.PubMedCrossRefGoogle Scholar
  66. 66.
    Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277(10):813–7.PubMedCrossRefGoogle Scholar
  67. 67.
    Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004;62(7):1148–55.PubMedCrossRefGoogle Scholar
  68. 68.
    Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol. 1997;56(2):165–70.PubMedCrossRefGoogle Scholar
  69. 69.
    Khan A, Kalaria RN, Corbett A, Ballard C. Update on Vascular Dementia. J Geriatr Psychiatry Neurol. 2016;29(5):281–301.PubMedCrossRefGoogle Scholar
  70. 70.
    Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci. 2002;203–204:7–10.PubMedCrossRefGoogle Scholar
  71. 71.
    Bruandet A, Richard F, Bombois S, Maurage CA, Deramecourt V, Lebert F, et al. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry. 2009;80(2):133–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer’s disease, vascular dementia and frontotemporal dementia. J Neurol Sci. 2005;236(1–2):43–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Staekenborg SS, Su T, van Straaten EC, Lane R, Scheltens P, Barkhof F, et al. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry. 2010;81(5):547–51.PubMedCrossRefGoogle Scholar
  74. 74.
    Ballard C, Neill D, O’Brien J, McKeith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord. 2000;59(2):97–106.PubMedCrossRefGoogle Scholar
  75. 75.
    Chiu PY, Liu CH, Tsai CH. Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia. Acta Neurol Taiwanica. 2007;16(2):86–91.Google Scholar
  76. 76.
    Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia. J Neurol Neurosurg Psychiatry. 2005;76(10):1337–41.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Parikh RM, Eden DT, Price TR, Robinson RG. The sensitivity and specificity of the Center for Epidemiologic Studies Depression Scale in screening for post-stroke depression. Int J Psychiatry Med. 1988;18(2):169–81.PubMedCrossRefGoogle Scholar
  79. 79.
    Agrell B, Dehlin O. Comparison of six depression rating scales in geriatric stroke patients. Stroke. 1989;20(9):1190–4.PubMedCrossRefGoogle Scholar
  80. 80.
    Critchley M. Atherosclerotic parkinsonism. Brain. 1929;52:23–83.CrossRefGoogle Scholar
  81. 81.
    Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger’s disease. Mov Disord. 1987;2(1):1–8.PubMedCrossRefGoogle Scholar
  82. 82.
    FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord. 1989;4(3):249–60.PubMedCrossRefGoogle Scholar
  83. 83.
    Chang CM, Yu YL, Ng HK, Leung SY, Fong KY. Vascular pseudoparkinsonism. Acta Neurol Scand. 1992;86(6):588–92.PubMedCrossRefGoogle Scholar
  84. 84.
    Meyer JS, Barron DW. Apraxia of Gait: a clinicophysiological study. Brain. 1960;83:261–84.CrossRefGoogle Scholar
  85. 85.
    Carboncini MC, Volterrani D, Bonfiglio L, Barsotti G, Della Porta M, Mariani G, et al. Higher level gait disorders in subcortical chronic vascular encephalopathy: a single photon emission computed tomography study. Age Ageing. 2009;38(3):302–7.PubMedCrossRefGoogle Scholar
  86. 86.
    Juva K, Makela M, Erkinjuntti T, Sulkava R, Ylikoski R, Valvanne J, et al. Functional assessment scales in detecting dementia. Age Ageing. 1997;26(5):393–400.PubMedCrossRefGoogle Scholar
  87. 87.
    Hershey LA, Jaffe DF, Greenough PG, Yang SL. Validation of cognitive and functional assessment instruments in vascular dementia. Int J Psychiatry Med. 1987;17(2):183–92.PubMedCrossRefGoogle Scholar
  88. 88.
    Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRefGoogle Scholar
  89. 89.
    Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–59.PubMedCrossRefGoogle Scholar
  90. 90.
    Tulving E, Craik FIM. The Oxford handbook of memory, vol. xiv. Oxford, New York: Oxford University Press; 2000. p. 700.Google Scholar
  91. 91.
    Yamamoto Y, Ihara M, Tham C, Low RW, Slade JY, Moss T, et al. Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke. 2009;40(6):2004–11.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol. 1979;36(2):65–73.PubMedCrossRefGoogle Scholar
  93. 93.
    de Jong G, Kessels F, Lodder J. Two types of lacunar infarcts: further arguments from a study on prognosis. Stroke. 2002;33(8):2072–6.PubMedCrossRefGoogle Scholar
  94. 94.
    Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27(8):1274–82.PubMedCrossRefGoogle Scholar
  96. 96.
    Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–22.PubMedCrossRefGoogle Scholar
  97. 97.
    Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol. 1987;44(1):21–3.PubMedCrossRefGoogle Scholar
  98. 98.
    Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318–22.PubMedCrossRefGoogle Scholar
  99. 99.
    Wen W, Sachdev PS, Li JJ, Chen X, Anstey KJ. White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44–48. Hum Brain Mapp. 2009;30(4):1155–67.PubMedCrossRefGoogle Scholar
  100. 100.
    Kapeller P, Barber R, Vermeulen RJ, Ader H, Scheltens P, Freidl W, et al. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke. 2003;34(2):441–5.PubMedCrossRefGoogle Scholar
  101. 101.
    Anbeek P, Vincken KL, van Osch MJ, Bisschops RH, van der Grond J. Probabilistic segmentation of white matter lesions in MR imaging. NeuroImage. 2004;21(3):1037–44.PubMedCrossRefGoogle Scholar
  102. 102.
    Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN, et al. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology. 2011;76(17):1478–84.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006;37(2):550–5.PubMedCrossRefGoogle Scholar
  104. 104.
    Roob G, Fazekas F. Magnetic resonance imaging of cerebral microbleeds. Curr Opin Neurol. 2000;13(1):69–73.PubMedCrossRefGoogle Scholar
  105. 105.
    Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol. 2010;119(3):291–302.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Ayaz M, Boikov AS, Haacke EM, Kido DK, Kirsch WM. Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging. 2010;31(1):142–8.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Dziewulska D. Mysteries of CADASIL—the contribution of neuropathology to understanding of the disease. Folia Neuropathol. 2009;47(1):1–10.PubMedGoogle Scholar
  108. 108.
    Goto Y. Clinical application of molecular diagnosis for mitochondrial encephalomyopathies. Hokkaido Igaky Zasshi. 1992;67(1):27–39.Google Scholar
  109. 109.
    Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):907–11.PubMedCrossRefGoogle Scholar
  110. 110.
    McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–7.PubMedCrossRefGoogle Scholar
  111. 111.
    Brodaty H, Clarke J, Ganguli M, Grek A, Jorm AF, Khachaturian Z, et al. Screening for cognitive impairment in general practice: toward a consensus. Alzheimer Dis Assoc Disord. 1998;12(1):1–13.PubMedCrossRefGoogle Scholar
  112. 112.
    Pantoni L, Rossi R, Inzitari D, Bianchi C, Beneke M, Erkinjuntti T, et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. J Neurol Sci. 2000;175(2):124–34.PubMedCrossRefGoogle Scholar
  113. 113.
    Wang S, Yang H, Zhang J, Zhang B, Liu T, Gan L, et al. Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. BMC Complement Altern Med. 2016;16:361.PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.PubMedCrossRefGoogle Scholar
  115. 115.
    Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol. 2008;64(1):97–108.PubMedPubMedCentralCrossRefGoogle Scholar
  116. 116.
    Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–9.PubMedCrossRefGoogle Scholar
  117. 117.
    PeBenito R. Developmental Gerstmann syndrome: case report and review of the literature. J Dev Behav Pediatr. 1987;8(4):229–32.PubMedCrossRefGoogle Scholar
  118. 118.
    Chen Y, Patel NC, Guo JJ, Zhan S. Antidepressant prophylaxis for poststroke depression: a meta-analysis. Int Clin Psychopharmacol. 2007;22(3):159–66.PubMedCrossRefGoogle Scholar
  119. 119.
    Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry. 2010;67(2):187–96.PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    Mead GE, Hsieh CF, Hackett M. Selective serotonin reuptake inhibitors for stroke recovery. JAMA. 2013;310(10):1066–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Amer M. Burhan
    • 1
  • Manoosh Moradizadeh
    • 2
  • Nicole E. Marlatt
    • 3
  1. 1.Parkwood Institute-Mental Health/Western UniversityLondonCanada
  2. 2.Parkwood Institute-Mental HealthLondonCanada
  3. 3.St. Joseph’s Health Care London, Parkwood InstituteLondonCanada

Personalised recommendations